Biotech company focused on therapeutics targeting the endocannabinoid system
Tetra Pharm Technologies has raised €9.0M across 1 funding round from 5 investors, most recently a Series A round in Jan 2023. Based in Copenhagen, Denmark; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-01-26 | Series A |
| €9.0M |
| Enexis AB,Leafy Tunnel,Nesroht Holding,Ole GS Holding,Rump Invest |
| View deal → |
